Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 10:44 PM
Study NCT ID:
NCT05966467
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2023-07-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2030-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-07
First Submit QC Date:
None
Study First Post Date:
2023-07-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED